Invus Public Equities, L.P.

Invus Public Equities, L.P. has an estimated net worth of $189 Million. This is based on reported shares across multiple companies, which include Omega Therapeutics, Inc., Seer, Inc., Generation Bio Co., SQZ Biotechnologies Co, Scholar Rock Holding Corp, LEXICON PHARMACEUTICALS, INC., GLYCOMIMETICS INC, Furiex Pharmaceuticals, Inc., ANTIGENICS INC /DE/, and NITROMED INC.

2018 was Invus Public Equities, L.P.'s most active year for acquiring shares with 23 total transactions. Invus Public Equities, L.P.'s most active month to acquire stocks was the month of May. 2024 was Invus Public Equities, L.P.'s most active year for disposing of shares, totalling 16 transactions. Invus Public Equities, L.P.'s most active month to dispose stocks was the month of July. 2014 saw Invus Public Equities, L.P. paying a total of $149,999,999.65 for 149,253,731 shares, this is the most they've acquired in one year. In 2024 Invus Public Equities, L.P. cashed out on 5,431,854 shares for a total of $82,886,387.88, their largest year based on trade value.